公司资料
KALA BIO 股价、新闻与催化剂
- 股票代码:
- KALA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.82 USD (-2.38%)
收盘价
最后更新: 2026年8月21日
44.4M USD
市值
股价为何变动
As of Aug 21, 2026, KALA closed down 2.38% at $0.8201. No new same-company headline was identified in the current news window.
公司概览
业务概览
KALA BIO is an eye-care biotechnology company focused on corneal and ocular surface disease. Its story centers on developing therapies for chronic ophthalmic conditions with limited treatment options.
所在地与行业分类
KALA BIO is headquartered in the United States and listed on NASDAQ. It sits in ophthalmology biotechnology.
商业模式特征
The company depends on clinical progress, regulatory milestones, and the ability to commercialize a focused eye-care pipeline. Investors watch data, safety, and access strategy.
生物医药行业定位
KALA occupies a niche ophthalmology position within biotech. It is catalyst-sensitive because eye-disease programs often hinge on a narrow set of data events.
未来催化剂
- KALA Bio is largely a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. There is no live standalone growth story left.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。